FDA Determines Regulatory Review Period for BIOMIMICS 3D VASCULAR STENT SYSTEM Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the BIOMIMICS 3D VASCULAR STENT SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).